Voleon Capital Management Portfolio holdings
Voleon Capital Management is a computer-driven investment firm that uses machine learning, statistical models that look for lasting patterns in large amounts of market data, to make trading decisions. Michael Kharitonov and Jon McAuliffe, two PhDs who had worked at D. E. Shaw & Co., founded it in 2007, once computers and data sets were powerful enough to make machine learning workable for investing. Kharitonov is its chief executive and McAuliffe a co-chief investment officer. Its clients include private investment funds and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$41.7M |
| 2 |
Meta Platforms (Facebook)
META
|
+$41.2M |
| 3 |
Merck
MRK
|
+$26.1M |
| 4 |
Intuit
INTU
|
+$24.7M |
| 5 |
AstraZeneca
AZN
|
+$23.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$29.3M |
| 2 |
Qualcomm
QCOM
|
+$28.6M |
| 3 |
Fortinet
FTNT
|
+$26.2M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$22.1M |
| 5 |
Eli Lilly
LLY
|
+$20.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.25% |
| 2 | Financials | 12.04% |
| 3 | Healthcare | 11.39% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
NVIDIA
NVDA
$5.2T
| $297M | 5.41% |
1,483,374
-100,495
| -6% | -$20.7M |
2024 Q4
6 quarters
|
|
2
Apple
AAPL
$5.02T
| $291M | 5.3% |
1,004,651
-28,079
| -3% | -$8.03M |
2024 Q4
6 quarters
|
|
|
3
Microsoft
MSFT
$3.94T
| $214M | 3.9% |
574,093
+103,098
| +22% | +$41.7M |
2024 Q4
6 quarters
|
|
|
4
Alphabet (Google) Class A
GOOGL
$3.97T
| $208M | 3.79% |
582,524
-61,313
| -10% | -$22.1M |
2024 Q4
6 quarters
|
|
5
Amazon
AMZN
$2.75T
| $151M | 2.76% |
634,323
+4,275
| +0.7% | +$1.07M |
2024 Q4
6 quarters
|
|
|
6
Meta Platforms (Facebook)
META
$1.59T
| $108M | 1.97% |
191,795
+67,391
| +54% | +$41.2M |
2024 Q4
6 quarters
|
|
7
Tesla
TSLA
$1.6T
| $96.6M | 1.76% |
229,701
+41,418
| +22% | +$16.5M |
2024 Q4
6 quarters
|
|
8
Micron Technology
MU
$1.11T
| $80.2M | 1.46% |
69,460
-19,534
| -22% | -$14.6M |
2025 Q2
4 quarters
|
|
9
JPMorgan Chase
JPM
$901B
| $78.1M | 1.42% |
238,577
+75,061
| +46% | +$23.3M |
2024 Q4
6 quarters
|
|
10
Broadcom
AVGO
$1.68T
| $72.6M | 1.32% |
192,127
-17,667
| -8% | -$7.08M |
2024 Q4
6 quarters
|
|
11
Mastercard
MA
$535B
| $70M | 1.28% |
136,289
+21,066
| +18% | +$10.5M |
2024 Q4
6 quarters
|
|
12
Sandisk
SNDK
$203B
| $66.2M | 1.21% |
29,114
-9,223
| -24% | -$13.2M |
2025 Q3
3 quarters
|
|
|
13
Eli Lilly
LLY
$1.15T
| $63.9M | 1.17% |
53,311
-20,365
| -28% | -$20.8M |
2024 Q4
6 quarters
|
|
14
Intel
INTC
$505B
| $61.7M | 1.13% |
442,176
+97,645
| +28% | +$9.9M |
2024 Q4
6 quarters
|
|
|
15
Astera Labs
ALAB
$51.6B
| $52.5M | 0.96% |
108,611
-110,232
| -50% | -$29.3M |
2025 Q3
3 quarters
|
|
16
O'Reilly Automotive
ORLY
$73.2B
| $50.8M | 0.93% |
551,949
+139,711
| +34% | +$12.7M |
2024 Q4
6 quarters
|
|
17
Chipotle Mexican Grill
CMG
$36.4B
| $47.5M | 0.87% |
1,398,527
+216,267
| +18% | +$7.06M |
2024 Q4
6 quarters
|
|
18
AbbVie
ABBV
$505B
| $43.5M | 0.79% |
172,753
+8,749
| +5% | +$1.88M |
2024 Q4
6 quarters
|
|
19
Visa
V
$752B
| $40.6M | 0.74% |
118,280
-10,421
| -8% | -$3.35M |
2024 Q4
6 quarters
|
|
20
Cardinal Health
CAH
$56.7B
| $40.1M | 0.73% |
168,918
+81,316
| +93% | +$16.9M |
2024 Q4
6 quarters
|
|
21
Walmart Inc
WMT
$942B
| $39.6M | 0.72% |
350,072
+45,356
| +15% | +$5.63M |
2024 Q4
6 quarters
|
|
|
22
Merck
MRK
$348B
| $38M | 0.69% |
295,499
+222,820
| +307% | +$26.1M |
2024 Q4
6 quarters
|
|
23
Solstice Advanced Materials
SOLS
$10B
| $35.7M | 0.65% |
403,405
+213,856
| +113% | +$17.6M |
2026 Q1
1 quarter
|
|
24
General Dynamics
GD
$95.9B
| $34.7M | 0.63% |
98,028
+44,200
| +82% | +$15.1M |
2024 Q4
6 quarters
|
|
25
Home Depot
HD
$317B
| $34.7M | 0.63% |
98,332
+3,467
| +4% | +$1.13M |
2024 Q4
6 quarters
|
|
Similar funds
Voleon Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
- Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
- Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
- Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
- Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
- Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
- Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
- Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.
Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.